GSK Files for Licensure of Priorix MMR Vaccine in the US

August 2, 2021 -- GSK today announced it has submitted a Biologics License Application (BLA) to the US Food and Drug Administration (FDA) for Priorix (Measles, Mumps, and Rubella Virus Vaccine, Live) and is seeking approval for use in active...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news

Related Links:

Vaccine. 2021 Dec 24:S0264-410X(21)01630-3. doi: 10.1016/j.vaccine.2021.12.022. Online ahead of print.ABSTRACTThe COVID-19 pandemic disrupted routine vaccinations for children and adolescents. However, it remains unclear whether the impact has been different for children and adolescents from low-income families. To address this, we compared monthly routine vaccination use per 1000 vaccine-eligible children and adolescents enrolled in Louisiana Medicaid in the years before (2017-2019) and during the COVID-19 pandemic (2020). Compared to the 2017-2019 average vaccination rates, we found a 28% reduction in measles, mumps, and...
Source: Vaccine - Category: Allergy & Immunology Authors: Source Type: research
Despite high rate of vaccination coverage with 2-doses of measles containing vaccine among Iranian children, outbreaks of measles occurred among different age groups and fully vaccinated subjects. Although the...
Source: BMC Immunology - Category: Allergy & Immunology Authors: Tags: Research Source Type: research
We reported three cases of immune thrombocytopenia (ITP) that developed within 6 weeks after ChAdOx1 nCoV-19 vaccination. Antiplatelet factor 4 antibodies were undetectable in all three cases. Therefore, vaccine-induced immune thrombotic thrombocytopenia was very unlikely. Other potential causes of thrombocytopenia were excluded. Their clinical presentations, severity of thrombocytopenia and outcomes were varied. Only one ITP case, an 80-year-old man, received ITP treatments and achieved complete response after 2 weeks of eltrombopag. An 84-year-old man had spontaneous complete remission, and a 55-year-old woman had partia...
Source: Blood Coagulation and Fibrinolysis - Category: Hematology Tags: CASE REPORT Source Type: research
In this study we investigate whether the accelerated schedule of MMR2 leads to a change in coverage of MMR2 and other childhood vaccines with an ecological study using childhood immunisation data from 2009 to 2018 in London.METHODS: We modelled coverage used generalized estimating equations (GEE) adjusted for year and DTaP/IPV/Hib3 coverage measured at 2nd birthday as a proxy for baseline local vaccination programme performance to determine the percentage point difference in coverage of MMR2 and other childhood vaccines.RESULTS: Average MMR2 coverage was higher among early implementing boroughs from 2012/13 onwards. Covera...
Source: Vaccine - Category: Allergy & Immunology Authors: Source Type: research
Conditions:   Immunotoxicity;   Vaccine Intervention:   Biological: Measles, Mumps and Rubella Combined Vaccine, Live Sponsor:   Shanghai Institute Of Biological Products Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Drugs & Pharmacology | Food and Drug Administration (FDA) | Measles | Measles Vaccine | Mumps | Mumps Vaccine | New Drug Applications | Rubella | Rubella Vaccine | Vaccines